Correction: Rewriting the script: gene therapy and genome editing for von Willebrand Disease
Alastair Barraclough, Isabel Bär, Tirsa van Duijl, Karin Fijnvandraat, Jeroen C. J. Eikenboom, Frank W. G. Leebeek, Ruben Bierings, Jan Voorberg, Despoina Trasanidou
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPlatelet Disorders and Treatments · Hemophilia Treatment and Research · CRISPR and Genetic Engineering
There was a mistake in the caption of Figure 1 as published. The legend of Figure 1 included text from an older version of the figure, which should have been removed. The incorrect caption read: Overview of von Willebrand Disease sub-types, von Willbrand Factor (VWF) domains, and variant distributions. (A) Summary of von Willebrand Disease sub-types (A) Von Willebrand Factor domains and binding sites. (B) Distribution and frequency of von Willebrand Factor variants curated in the Leiden Open Variation Database (LOVD) (Accessed and data retrieved on 8-1-2025). Created in BioRender.
The corrected caption of Figure 1 appears below.
Overview of von Willbrand Factor (VWF) domains, and variant distributions. (A) Von Willebrand Factor domains and binding sites. (B) Distribution and frequency of von Willebrand Factor variants curated in the Leiden Open Variation Database (LOVD) (Accessed and data retrieved on 8-1-2025). Created in BioRender.
The original article has been updated.